Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: CStone Pharma, a Suzhou Oncology Company, Files for Hong Kong IPO
Week in Review: bioMérieux Acquires Majority Stake in China Diagnostics Company for $114 Million
Week in Review: Terns Raises $80 Million for China, Global Development of Drugs Licensed from Lilly
Week in Review: Innovent Completes $421 Million Hong Kong IPO; Will Start Trading Next Week
Week in Review: Innovent's Hong Kong IPO: Raising $422 Million at $2 Billion Valuation
Upcoming event
ChinaBio Partnering Forum 2019
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events